P-选择素抗体治疗钝性胸部创伤后可预防早期肺动脉血栓形成且不改变黏弹性凝血检测指标
本研究在钝性胸部创伤小鼠模型中,于伤后30分钟分别给予P-选择素阻断抗体、同型对照抗体、低剂量肝素、高剂量肝素或生理盐水,90分钟时采血用黏弹性凝血监测仪(VCM Vet)检测凝血时间、凝血形成时间、α角和最大血凝块强度。结果:接受P-选择素抗体的小鼠动脉纤维蛋白沉积较同型对照组减少4–5倍(p<0.001);假手术组和创伤组中,与单用溶媒(生理盐水)相比,P-选择素抗体、同型对照或低剂量肝素注射后各项凝血参数均无统计学差异;盲法组织病理学评估显示P-选择素阻断抗体组与同型抗体对照组出血评分无差异。作者认为该研究支持P-选择素阻断抗体用于钝性胸部创伤后预防肺血栓形成的临床可行性。
要点
- 小鼠钝性胸部创伤后30分钟给予P-选择素阻断抗体,动脉纤维蛋白沉积较同型对照组减少4–5倍(p<0.001)。
- 假手术组和创伤组中,与生理盐水相比,P-选择素抗体、同型对照或低剂量肝素注射后黏弹性凝血参数均无统计学差异。
- 盲法组织病理学评估显示,P-选择素阻断抗体组与同型抗体对照组出血评分无差异。
- 作者认为P-选择素抗体不影响全身凝血,可在创伤后急性期安全给药。
适用人群与场景
- 钝性胸部创伤小鼠模型;分为假手术对照组和实验性创伤组。
处置流程与药物剂量
- 创伤后30分钟给予P-选择素阻断抗体、同型对照抗体、低剂量肝素、高剂量肝素或生理盐水。
- 创伤后90分钟采集全血,用黏弹性凝血监测仪(VCM Vet;Entegrion,达勒姆,北卡罗来纳州)检测凝血时间、凝血形成时间、α角和最大血凝块强度。
研究设计与关键结果
- 研究类型:小鼠钝性胸部创伤模型实验;样本量原文未报告。
- 接受P-选择素抗体的小鼠动脉纤维蛋白沉积较同型对照组减少4–5倍(p<0.001)。
- 假手术组和创伤组中,与单用溶媒(生理盐水)相比,P-选择素抗体、同型对照或低剂量肝素注射后各项凝血参数均无统计学差异。
- 盲法组织病理学评估显示,P-选择素阻断抗体组与同型抗体对照组出血评分无差异。
证据类型、等级与局限
- 证据类型:动物实验(小鼠模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,该研究支持P-选择素阻断抗体用于钝性胸部创伤后预防肺血栓形成的临床可行性。
- 作者认为,P-选择素抗体不 adverse 影响以黏弹性检测评估的全身凝血,提示可在创伤后急性期安全给药。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Previously, in a murine model of blunt thoracic trauma, we provided evidence of primary pulmonary thrombosis associated with increased expression of the cell adhesion molecule, P-selectin. In this study, mice are treated with P-selectin blocking antibody after injury to investigate the clinical viability of this antibody for the prevention of pulmonary thrombosis. In addition, viscoelastic testing is performed to investigate if P-selectin inhibition has a detrimental impact on normal hemostasis.
METHODS: A murine model of thoracic trauma was used. Mice were divided into sham control and experimental injury groups. Thirty minutes after trauma, mice were treated with the following: P-selectin blocking antibody, isotype control antibody, low-dose heparin, high-dose heparin, or normal saline. At 90 minutes, whole blood was collected for characterization of coagulation by viscoelastic coagulation monitor (VCM Vet; Entegrion, Durham, NC). Mean clotting time, clot formation time, clot kinetics (α angle), and maximum clot firmness were compared between each treatment group.
RESULTS: Mice that received P-selectin antibody 30 minutes after blunt thoracic trauma had four- to fivefold less (p < 0.001) arterial fibrin accumulation than those that received the isotype control. In both sham and trauma groups, compared with vehicle (normal saline) alone, no statistical difference was noted in any coagulation parameters after injection with P-selectin antibody, isotype control, or low-dose heparin. In addition, blinded histopathological evaluation yielded no difference in hemorrhage scores between injured mice treated with P-selectin blocking antibody and those treated with isotype antibody control.
CONCLUSION: This study supports the clinical use of P-selectin blocking antibody for the prevention of pulmonary thrombosis by confirming its efficacy when given after a blunt thoracic trauma. In addition, we demonstrated that the administration of P-selectin antibody does not adversely affect systemic coagulation as measured by viscoelastic testing, suggesting that P-selectin antibody can be safely given during the acute posttraumatic period.
参考来源
- Schutzman LM, Rigor RR, Lin YJ, et al. P-selectin antibody treatment after blunt thoracic trauma prevents early pulmonary arterial thrombosis without changes in viscoelastic measurements of coagulation. J Trauma Acute Care Surg. 2021. PMID: 34016926. doi:10.1097/TA.0000000000003162
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。